Immunology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Immunology Case Reports (2023) Volume 6, Issue 3

Barrier surfaces help to protect the body's first line of defence

Nikita Patel*

Department of Immunology, University of Gothenburg, Sweden

*Corresponding Author:
Nikita Patel
Department of Immunology
University of Gothenburg

Received:15-May-2023, Manuscript No. AAICR-23-101414; Editor assigned:17-May-2023, PreQC No. AAICR-23-101414(PQ); Reviewed:01-Jun-2023, QC No. AAICR-23-101414; Revised:05-Jun-2023, Manuscript No. AAICR-23-101414(R); Published:12-Jun-2023, DOI:10.35841/aaicr-6.3.146

Citation: Patel N. Barrier surfaces help to protect the body's first line of defence. Immunol Case Rep. 2023;6(3):146

Visit for more related articles at Immunology Case Reports


Our bodies are constantly exposed to a myriad of potential threats, ranging from harmful pathogens to environmental toxins. To ensure our overall health and well-being, the immune system deploys an intricate network of defenses, including the immunology of barrier surfaces. These barrier surfaces act as the body's first line of defense against invading microorganisms and play a crucial role in maintaining our health. In this article, we will delve into the fascinating world of the immunology of barrier surfaces and explore how these defenses protect us from harmful pathogens. Barrier surfaces refer to the various interfaces between the external environment and our internal tissues. The skin, respiratory tract, gastrointestinal tract, and genitourinary tract are the primary barrier surfaces of our body. These surfaces are lined with specialized cells and tissues that form physical and biochemical barriers to prevent the entry of pathogens into the body [1].

Let's begin with the skin, the largest and most visible barrier surface. The skin acts as a physical barrier, preventing the penetration of microbes and environmental toxins. The outermost layer of the skin, called the stratum corneum, consists of multiple layers of dead skin cells that form a tough, impermeable barrier. Additionally, the skin produces antimicrobial peptides, such as defensins, which can directly kill invading pathogens. If the skin is breached due to a cut or wound, immune cells, such as neutrophils and macrophages, are recruited to the site to eliminate any potential threats and facilitate the healing process. Moving on to the respiratory tract, it is constantly exposed to airborne pathogens and particulate matter. The respiratory epithelium is lined with specialized cells, including cilia and mucus-producing goblet cells. The coordinated movement of cilia helps to sweep away trapped pathogens and debris from the airways, preventing them from reaching the lungs. The mucus layer, rich in antimicrobial substances like lysozyme and lactoferrin, further aids in trapping and neutralizing pathogens. In case any microorganisms manage to breach these barriers, immune cells present in the respiratory tract, such as alveolar macrophages, dendritic cells, and lymphocytes, quickly recognize and eliminate the invaders [2].

The gastrointestinal tract is another critical barrier surface that encounters a wide range of potential pathogens through the ingestion of food and water. The epithelial cells lining the intestines form a tightly packed layer held together by proteins called tight junctions. These junctions prevent the leakage of harmful substances and pathogens into the bloodstream. Furthermore, the gut-associated lymphoid tissue (GALT), including Peyer's patches and lymphoid follicles, plays a vital role in immune surveillance. The GALT contains specialized immune cells that sample the intestinal contents for any foreign invaders and mount an immune response if necessary. The gut microbiota, the collection of beneficial bacteria residing in the intestines, also contributes to the barrier function by competing with harmful pathogens for resources and producing antimicrobial compounds [3].

The genitourinary tract, encompassing the urinary and reproductive systems, also possesses barrier mechanisms to fend off potential pathogens. In the urinary system, the epithelial lining of the bladder and urethra produces a protective layer of glycosaminoglycans, which help prevent the attachment and invasion of bacteria. Additionally, urine flow acts as a mechanical washout, flushing out any pathogens that may have entered the urinary tract. The reproductive system, in both males and females, has mucosal surfaces lined with specialized cells that secrete antimicrobial peptides, antibodies, and mucus to provide a defense against sexually transmitted infections [4].

While often overlooked, the eye and oral cavity are crucial barrier surfaces with their immune defense mechanisms. Tears in the eyes contain antimicrobial proteins, such as lysozyme, while the oral cavity's saliva contains enzymes that break down pathogens. Specialized immune cells, such as neutrophils and secretory IgA, provide additional protection by detecting and neutralizing potential threats. While each barrier surface has its unique set of defense mechanisms, they all share certain common features. These include physical barriers, such as epithelial cells and mucus, which prevent infections [5].


The immunology of barrier surfaces is an intricate and vital aspect of our body's defense system. The skin, respiratory tract, gastrointestinal tract, genitourinary tract, eyes, and oral cavity collectively form an intricate network of barriers and immunological defenses that work harmoniously to protect our bodies from harmful pathogens. These barrier surfaces are equipped with an array of physical, chemical, and cellular mechanisms that ensure our overall health and well-being.


  1. Wang Z, MacLeod DT, Di Nardo A. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J Immunol. 2012;189(4):1551–8.
  2. Indexed at, Google Scholar, Cross Ref

  3. Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131(3):688–97.
  4. Indexed at, Google Scholar, Cross Ref

  5. Sanchez R, Mohr I. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein . J Virol. 2007;81(7):3455–64.
  6. Indexed at, Google Scholar, Cross Ref

  7. Peng T, Zhu J, Klock A, et al. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J Virol. 2009;83(23):12559–68.
  8. Indexed at, Google Scholar, Cross Ref

  9. Sieprawska-Lupa M, Mydel P, Krawczyk K, et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother. 2004;48(12):4673–9.
  10. Indexed at, Google Scholar, Cross Ref

Get the App